Sort
261,768 grants matching “gene therapy”
Cell Prep Core
$1,551,155John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Repurposing misoprostol to prevent recurrence of Clostridium difficile infection
$1,551,088David M Aronoff · Vanderbilt University Medical Center · U01 · FY2018 · TR
Pacific Udall Center
$1,550,974Thomas J Montine · Stanford University · P50 · FY2017 · NS
Processing of Complex Lesions in the Mammalian Genome
$1,550,890Randy J Legerski · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
Repurposing misoprostol to prevent recurrence of Clostridium difficile infection
$1,550,850Ryan S Doster · Vanderbilt University Medical Center · U01 · FY2019 · TR
Mental Retardation &Developmental Disabilities Research
$1,550,724Children'S Hospital Boston · P30 · FY2002 · HD
BIOLOGY AND TRANSPLANTATION OF THE HUMAN STEM CELL
$1,550,643University Of Minnesota Twin Cities · P01 · FY2004 · CA
OPTIMIZE - CCC - Lead Application
$1,550,633Bonnie W Ramsey · Seattle Children'S Hospital · U01 · FY2015 · HL
Circuit-specific, chemogenetic neuromodulation in nonhuman primates.
$1,550,458Charles E Schroeder · Nathan S. Kline Institute For Psych Res · UG3 · FY2023 · MH
Building an Implantable Artificial Kidney
$1,550,172Shuvo Roy · University Of California, San Francisco · U01 · FY2017 · EB
The heterogeneous HIV expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound
$1,550,158Steven A Yukl · University Of California, San Francisco · P01 · FY2024 · AI
The heterogeneous HIV expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound
$1,550,033Steven A Yukl · University Of California, San Francisco · P01 · FY2025 · AI
The heterogeneous HIV expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound
$1,549,996Steven A Yukl · University Of California, San Francisco · P01 · FY2023 · AI
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
$1,549,888Daniel Woo · University Of Cincinnati · R01 · FY2012 · NS
Understanding and Improving Therapies for the Muscular Dystrophies
$1,549,615Hugh Lee Sweeney · University Of Florida · P50 · FY2023 · AR
Understanding and Improving Therapies for the Muscular Dystrophies
$1,549,615Hugh Lee Sweeney · University Of Florida · P50 · FY2022 · AR
Structure-Function Studies of the HIV-1 Envelope Glycoproteins
$1,549,551Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Gene Therapy for Batten Disease
$1,549,439Ronald G Crystal · Weill Medical Coll Of Cornell Univ · U01 · FY2009 · NS
Biological Breast Cancer Classification by qRT-PCR
$1,549,377Matthew J Ellis · Washington University · U01 · FY2007 · CA
Gene Therapy for Alzheimer's Disease
$1,549,290Mark H Tuszynski · University Of California, San Diego · P01 · FY2012 · AG
Unraveling the Mechanisms of HIV Persistence and Rebound
$1,548,855Thomas Hope · Northwestern University At Chicago · P01 · FY2023 · AI
Hypoxia--Molecular Studies and Clinical Exploitation
$1,548,838Stanford University · P01 · FY2005 · CA
MITOCHONDRIAL ENCEPHALOMYOPATHIES: APPROACHES TO TREATMENT
$1,548,815Salvatore Dimauro · Columbia University Health Sciences · P01 · FY2017 · HD
Mucosal Immune Defense Mechanisms of the Urinary Bladder
$1,548,815Marco Colonna · Washington University · U01 · FY2019 · AI
Unraveling the Mechanisms of HIV Persistence and Rebound
$1,548,796Thomas Hope · Northwestern University At Chicago · P01 · FY2025 · AI